Background: Essential oil obtained from rhizomes of the Zingiber zerumbet (L.) Smith (popularly known in Brazil as bitter ginger) is mainly constituted by the biomolecule zerumbone, which exhibit untapped antimicrobial potential.
mL/min with purity percentage of 99.999%. It was injected 1 μL in splitless mode, in 1:20 ratio of hexannic solution.
The oven was programmed at controlled temperature between 60-240° C, raising 3°C/min and kept at 250°C for 10 minutes. Temperature of mass transfer and injection were established at 220° C and 290° C, respectively. The chemical constituents of essential oil analyzed were expressed as relative percentage by peak area normalization. The identification of the OE constituents was done by calculating the retention time obtained in the analyzes of GC-MS, correlating them with the retention times of the n-alkanes (C9-C30). The indices were compared with the data available in the NIST / WILEY library [18] . The zerumbone identification was done as previously described [19] .
High-performance liquid Chromatography (HPLC)
After purification and recrystallization of the EO using our patented method (n 0 PI-0505343-9/28/11/2007), the zerumbone purity was estimated through HPLC analysis (Accela High Speed LC, Thermo Scientific®), using a column Hypersil Gold (50 x 2,1 mm) and a mobile phase methanol:water (85:15, v/v) at 1 mL/min. The identification was done by comparing the retention time of the peaks with those standard solutes in HPLC and confirmed by UV-absorption spectrum (~252 nm).
Inoculum standardization
The antimicrobial activity of the zerumbone was evaluated against the standard strain of S. mutans ATCC 35668 (American Type Culture Collection, Microbiologics Inc., St. Cloud, USA). Firstly, bacterial suspensions were prepared by inoculation of colonies into a tube containing 3 mL Brain Heart Infusion (BHI) broth, followed by incubation at orbital shaking of 150 RPM for 72 hours at 37 °C in anaerobic conditions, as previously described [20] . After incubation, the turbidity was calibrated and adjusted through spectrophotometer analysis to match the 0,5
MacFarland scale (1x10 8 CFU/mL). Final inoculum of 1 x 10 6 CFU/ mL was used in the assays.
Determination of the Antimicrobial Activity
The antimicrobial activity of zerumbone was evaluated by estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) using microdilution method according to the guidelines of the Clinical & Laboratory Standards Institute (CLSI) [21] . The concentrations of zerumbone tested were 2000; 1000; 500; 250 and 125 μg/mL. After diluting serially the zerumbone in 96 well-plate containing 100 μL BHI broth, 100 μL of BHI broth having bacterial inoculum (1x10 6 CFU/mL) were added into wells resulting in a final volume of 200 μL, followed by incubation at the same conditions mentioned above. Additional wells containing diluting agent of zerumbone (tween 20 10%) was used as a control.
After incubation, the bacterial growth was evaluated by measuring the turbidity in each well through spectrophotometric analysis (600nm). Subsequently, an aliquot of 50 μL of each well was collected and seeded on plates containing BHI agar and incubated for 72 hours at 37 °C in anaerobic conditions. Next, the plates were analyzed for the presence/absence of bacteria in order to estimate the MIC and MBC. All tests were performed in triplicate and repeated three times to verify the reproducibility of results.
Time-Kill Curve Assay
To determine the speed of cidal activity of the zerumbone, a time kill-curve was performed as previously described, with few modifications [22] . An inoculum of 1x10 6 CFU/mL was added into tubes having 3 mL of BHI broth or BHI broth treated with zerumbone (250 or 500 μg/mL) or tween 20 10% (control) and then incubated for 72 hours anaerobically with orbital rotation of 150 RPM at 37 °C . The tube containing only bacteria and BHI broth was used to estimate the different phases of growth curve.
An aliquot of 100 μL was removed at 0, 6, 12, 24, 48 and 72 h time intervals to determine the bacterial growth by measuring turbidity through spectrophotometric analysis (600nm). Subsequently, the aliquots were serially diluted in 0.85% of sterile saline solution, seeded in BHI agar and then incubated at the conditions set out above. The viable number of bacterial cells was estimated by counting CFU and multiplying the results by dilution factors. Means of duplicate colony counts were taken. To build the time-kill curve, the log 10 CFU/mL versus time over 72 h was plotted. The decrease of 99.9% (≥ 3 log 10 ) of the total number of CFU/mL in the original inoculum was used to estimate the bactericidal activity. The assays were performed in triplicate and repeated three times to confirm the reproducibility of results.
Cytotoxicity assay
The cytotoxicity activity of zerumbone was determined using the MTT (3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay as previously described with few modifications [20] . Summarily, VERO cells line (2 x 7 streptomycin and amphotericin B) per well, in atmosphere of 5% CO 2 at 37º C for 24 hours. After formation of subconfluent monolayer, the cells were treated with zerumbone (25 µg/mL; 50 µg/mL and 100 µg/mL) and incubated again at the same conditions above mentioned for 24 and 48 hours. Sterile PBS was used as positive control and DMSO 100% as negative control. Subsequently, the medium was removed from all wells and 10µL of MTT (5 mg/mL in sterile PBS) diluted in 100 µL of DMEM medium (without phenol red to avoid misinterpretation) was added into the wells and incubated in atmosphere of 5% CO 2 at 37º C for 4 hours. After that, the MTT was removed and 50µL of MTT lysis buffer were added to each well followed for gently homogenization to dissolve the formazan crystals and incubated again for 10 minutes at the same conditions mentioned earlier. Optical densities of samples were measured using a microplate reader at wavelength of 570 nm. The relative viability of cells was estimated using the following equation: (A570 of treated sample)/(A570 of untreated sample)×100. All tests were done in triplicate.
Results

Acquisition of Essential oil and purification of zerumbone
The yield of the essential oil obtained was 5%. The EO showed to be constituted mainly by sesquiterpene zerumbone compound, according to GC-MS analysis (figure 2). A percentage of 87,93% of zerumbone was detected among the nineteen others chemical constituents. The purification and recrystallization processes applied to EO resulted in a zerumbone crystal with 98% of purity (figure 3).These crystals were used in all subsequent tests.
Antimicrobial activity of zerumbone
The zerumbone demonstrated efficient antimicrobial activity against S. mutans ATCC 35668 showing a MIC value of ≥ 250 μg/mL and MBC of ≥ 500 μg/mL ( Figure 4 ). The MIC was determined according to lowest concentration of essential oil that inhibits the bacterial growth, whereas the MBC was assessed based on the concentration that kills all viable bacterial cells (supplementary figure 2).
Time-kill Curve
The time-kill curve assay corroborates the antimicrobial activity of the zerumbone. The zerumbone displayed more intense antibacterial activity in the time interval 12-48 hours, corresponding to log phase of S. mutans growth curve (supplementary figure 2). Within 12 hours of bacterial exposure to 250 μg/mL and 500 μg/mL of zerumbone concentrations, viable bacterial cells were reduced in 41,77% and 58,34%, respectively, in comparison to the original inoculum (figure 4 A). After 24 hours of exposure, the reduction was more pronounced with 64.29% (250 μg /mL) and 78.58% (500 μg/mL) of bacterial cells death (figure 4 B and C).Finally, the zerumbone showed its maximum action in the interval of 48-72 hours, reducing 96,88% of bacterial colonies at concentration of 250 μg/mL and killing all bacteria at the concentration of 500 μg/mL ( Figure 5 A, B and C ).
Cytotoxicity activity of zerumbone
The MMT assay demonstrated that the biomolecule zerumbone had no considerable cytotoxicity effect up to 100 μg/mL. At concentrations 25, 50 and 100 μg/mL the percentages of cell viability were 100, 97 and 92%, respectively, after 24 hours treatment ( figure 6 ). The cell viability slightly changed at concentration 50 μg/mL (95%) and 100 μg/mL (85%) after 48 hours treatment. The results clearly show that the zerumbone may have no cytotoxic effect on normal mammalian cells.
Discussion
Tooth decay disease is a growing global concern that threatens human health and safety [23] . Emerging resistance to conventional antibiotics associated to inconvenient side effects caused by commercial antibiotics usually result in treatment leaving [24] . In this regard, the development of alternative antibiotic therapies based on bioactive molecules from medicinal plants is urgent and crucial to provide effective prevention and treatment for toothinfection-causing bacteria.
This study demonstrated strong antimicrobial activity of zerumbone against the cariogenic agent S. mutans (MIC> 250 μg/ mL) according to the following classification of antimicrobial action: strong = 50<MIC<500 μg/mL moderate = MIC 600<MIC<1500 μg/mL and; weak = MIC>1500 μg/mL [25, 26] . Thus, our data bring to the light a new possibility of prophylactic and therapeutic strategies for S. mutans infection, especially in case of tooth decay, a serious public health issue [27] .
As a matter of fact, few reports have shown natural biomolecules antimicrobial activity against the S. mutans and the majority demonstrated weak antibacterial action based on the classification set out above [28] [29] [30] .A recent study tested around two thousand plant extracts from Amazon region against S. mutans (ATCC 25175) and, from this number, seventeen displayed antimicrobial activity, but only the extract obtained from Ipomoea alba L. sp (Convolvulaceae) showed antimicrobial activity considered strong (MBC> 160µg/mL) [31] .Takarada et al. [32] and Aguiar et al. [33] evaluated the anti-S. mutans activity of essential oils from the following plants: Romarinus officinalis L., Melaleuca alternifólia, Lavandula officinalis, Leptosperfum scoparium, Eucalyptus radiate, Ageratum conyzoides, Artemisia camphorata Vill., Bidens sulphurea, Foeniculum vulgare Mill., Lippia alba, Ocimum gratissimum L., Pelargonium graveolens, Syzygium aromaticum and Tagetes erecta L. The results showed MICs ranging from 500 to10,000 μg/mL, activities considered weak compared to our data. Therefore, these studies corroborate the strong bioactive potential of the zerumbone as anticariogenic agent, which could be a good substrate to be used in prophylactic and therapeutic formulations against tooth decay.
Indeed, the zerumbone has been tested against a range of microorganisms showing good antibacterial activity mainly against gram positive bacteria [34] . But, up to now, there is no report describing the antimicrobial activity of the zerumbone or its analogs against S. mutans. Hasan et al. [35] demonstrated that extracts from Zingiber officinale, specie that belongs to same genus and family of bitter ginger, has anti-S. mutans action with MIC value of 256 μg/mL, effect similar to the one observed for this study. However, differently from our study, no compound was isolated or purified to determine which biomolecules were responsible for the antimicrobial activity observed.
Generally, the essential oil obtained from Zingiber zerumbet shows in its constitution a range of zerumbone concentration starting from 12 to 73% [9] . Our results demonstrated that the essential oil obtained in this study showed 87,93% of zerumbone , which was raised to 98% after purification and recrystallization process using a method patented for our group (n 0 PI-0505343-9/28/11/2007). This purity degree usually is greater than the ones described elsewhere, which allow us to better characterize the zerumbone antimicrobial action [10] .
As the zerumbone exhibited efficient antimicrobial activity, we next evaluated the speed of cidal activity. The effectiveness observed was concentration and time-dependent, although both concentrations tested showed similar results. The intensity of zerumbone antimicrobial activity was more pronounced during the logarithmic growth phase. After 24 hours of bacterial exposure to 250 and 500 μg/mL zerumbone concentrations, viable bacterial cells were reduced 64.29% and 78.58%, respectively. According to Jones et al. [36] when an antimicrobial agent reduces the bacterial colonies around 70% within 24 hour time period, it can be considered as a strong candidate for treating bacterial infections. However, the maximum cidal activity of zerumbone was reached at stationary phase, suggesting the possibility of two mechanism of zerumbone activity, different from the most antibiotic agents that require cell division or active metabolism for the drug's killing activity [37, 38] . Thus, an antibiotic agent that still shows bactericidal activity under growth-limited conditions may be very advantageous, since the biofilm-associated microorganisms, such as S. mutans, may modulate gene expression to enhance endurance under periods of nutrient limitation to survive in the stationary phase [39] . Nevertheless, more studies are needed to elucidate the zerumbone antibacterial mechanism of action.
Extracts derived from Dodonaea viscosa plant killed 100% of S. mutans colonies within 24 h exposition [40] .
However, the concentration required to kill all bacteria was 12.500 mg/mL, value much higher than the one observed in this study. Nonetheless, it is important to emphasize that comparison of time-kill curve among different bacteria strains should be done carefully once the microbial growth logarithmical phase directly influences the action of antibacterial agent [41] .
Beyond the determination of the optimum antibacterial concentration, it is also important guarantee the cytotoxicity safety of the bioactive substances against normal mammalian cells, if the ultimate goal is to use it as a main raw material to produce new drugs. Usually, finding the balance between effectiveness and safety of a biomolecule it is very hard mission [42, 43] .Our findings indicated that the zerumbone is not cytotoxic to normal mammalian cells, since the exposure of VERO cells to different concentrations of zerumbone cause no considerable toxic effects. Even after 48 hours of zerumbone treatment, no substantial toxic effect was observed, other than a low cytotoxicity evidenced at 100µg/mL concentration (reduction of 15% of cell proliferation). However, it is imperative to consider that the susceptibility of mammalian cells tend to be greater in the MTT test than in vivo situation, because of the direct exposure of the cells to the biomolecules without any type of variants happening in vivo, such as route of administration and topical absorption, which may influence or even though decrease the cytotoxicity effect demonstrated in vitro [44] .
Altogether, this study demonstrated the zerumbone great antimicrobial activity against the S. mutans, showing that its toxic activity is selectively targeted to the bacterium, once the zerumbone did not display cytotoxic effect against the normal mammalian cells. However, further studies using in vitro and in vivo models are needed to better determine the zerumbone effectiveness and safety as antimicrobial agent in the context of prophylaxis and treatment of cariogenic infections.
Conclusions
In summary, this study suggests that the zerumbone represents an excellent bioactive substance to be explored by phytopharmaceutical industry in the drug formulations, to prevent and treat cariogenic infections, because this biomolecule showed an outstanding antimicrobial activity against the main etiological agent of tooth decay, S. mutans. Although the cytotoxicity safety of zerumbone in mammalian cells and its antibacterial action at both log and stationary phases support its potential use as antibacterial agent against S. mutans infection, additional studies are necessary to better characterize the zerumbone mechanism of action, efficacy and safety in the scenario of cariogenic disease. 
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